Telix Pharmaceuticals Limited Increase Decrease Through Business Combinations Deferred Tax Liability Asset
Telix Pharmaceuticals Limited (TLPPF) reported Increase Decrease Through Business Combinations Deferred Tax Liability Asset of -$24.54 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Notes › Income Taxes
ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset · last filed 2026-02-20
| Period end | Increase Decrease Through Business Combinations Deferred Tax Liability Asset 12 month |
|---|---|
| 2025-12-31 | -$24.54M 20-F · filed 2026-02-20 |